In another study, while 346 of 744 patients (46.5%) with HER2-negative GC were older than 59, a total of 63 of 94 patients (67.0%) with HER2-positive gastric cancer were older than 59 (p < 0.001) [32]. The gene discussed is ERBB2; the disease is gastric cancer.